Conventional therapies for inflammatory bowel diseases (IBD) involve combinations of
pharmacologic agents such as aminosalicylates, azathioprine, and corticosteroids. Recently …

Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis
(UC), are a major healthcare challenge worldwide. Disturbances in the immune system and …

Inflammatory bowel disease (IBD) is a chronic, non-specific inflammatory disease of the
intestine that can be classified as ulcerative colitis (UC) and Crohn's disease (CD) …

Inflammatory bowel disease (IBD) is a long-life disease with periods of recurrence and relief.
Oxidative stress plays an important role in the pathogenesis of this disease. Recent years' …

Inflammatory bowel disease (IBD) is a recurrent idiopathic inflammatory condition,
characterized by disruption of the gut mucosal barrier. This mechanistic review aims to …

Abstract Inflammatory Bowel Disease (IBD) is characterized by chronic inflammation of all or
part of the digestive tract. Nutraceuticals include bioactive compounds such as polyphenols …

Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) mainly affecting the
colon and the rectum. Its main characteristics include relapsing and remitting mucosal …

Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal
tract with unclear etiology, namely ulcerative colitis and Crohn's disease. Various drug …

Inflammatory bowel disease (IBD) is characterized by chronic inflammation of the intestine
that compromises the patients' life quality and requires sustained pharmacological and …

Accumulating epidemiological and clinical study indicates that inflammation is a significant
risk factor to develop various human diseases such as inflammatory bowel disease (IBD) …